Contact this trialFirst, we need to learn more about you.
Alkylating agent
Interleukin-2 + Dacarbazine for Melanoma
Recruiting1 awardPhase 2
Louisville, Kentucky
This trial is testing whether a combination of two existing cancer drugs is more effective and less toxic than current treatments for people with high-risk melanoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.